This supplement to The American Journal of Managed Care provides a clinical overview of restless legs syndrome, including epidemiology, etiology, and pathophysiology, as well as clinical features, impact on quality of life, and management.Faculty
Shyamal H. Mehta, MD, PhD
Assistant Professor
Movement Disorders Program
Georgia Health Sciences University
Augusta, Georgia
Kapil D. Sethi, MD, FRCP
Director
Movement Disorders Program
Professor of Neurology
Georgia Health Sciences University
Augusta, Georgia
Disclosures
These faculty report relationships with the following organizations:
Kapil D. Sethi, MD, FRCP
Consultant/Advisory Board: Impax, Teva
Employment (part-time): Merz Pharmaceuticals
Grants: Abbott, Acadia, Impax, National Institutes of Health, National Parkinson Foundation
Honoraria/lecture fees: Teva
Shyamal H. Mehta, MD, PhD
Consultant: Allergan Inc, GE Healthcare, Ipsen, Merz Pharmaceuticals, Teva, US World Meds
Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.
This supplement was supported by UCB, Inc.
The opinions expressed in this supplement are those of the authors, presenters, and/or panelists and are not attributable to the sponsor or the publisher, editor, or editorial board of The American Journal of Managed Care. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this supplement are not necessarily the same as indicated in the package insert for the product and may reflect the clinical experience of the authors, presenters, and/or panelists or may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.